GSK plc (GLAXF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 20.25 |
| Open | 20.25 |
| Bid | 19.26 x 40700 |
| Ask | 19.99 x 34100 |
| Day's range | 20.25 - 20.25 |
| 52-week range | 16.69 - 23.00 |
| Volume | |
| Avg. volume | 2,200 |
| Market cap | 81.563B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 14.29 |
| EPS (TTM) | 1.40 |
| Earnings date | 31 Jul 2024 |
| Forward dividend & yield | 0.77 (3.86%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
ZacksGSK (GSK) Earnings Expected to Grow: Should You Buy?
Glaxo (GSK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PA Media: MoneyGSK moves to new HQ in return to central London
Around 3,000 of the drug giant’s staff will be based at The Earnshaw building on the corner of New Oxford Street.
Business WireGSK Begins Shipping Influenza Vaccine Doses for 2024-25 Season
PHILADELPHIA, July 11, 2024--GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its trivalent influenza vaccines to US healthcare providers and pharmacies in preparation for the 2024-25 flu season. This immediately follows a licensing and lot-release approval from the US Food and Drug Administration (FDA).
© 2024 Yahoo. All rights reserved.